At NHMRC we are excited by the huge potential benefits of the research we fund and by the opportunities we have to ensure Australians have access to evidence-based, authoritative health advice.
We create pathways to a healthier future through our research funding, our health guidelines and the ethical standards we set and uphold.
As the nation’s leading expert body in health and medical research, we set ourselves high standards of integrity and scientific rigour, and see ourselves as championing the pursuit of better health outcomes for all Australians.
NHMRC Corporate Plan
The NHMRC Corporate Plan 2019–20 covers the period 2019–20 to 2022–23. In line with the requirements of the National Health and Medical Research Council Act 1992, it identifies the major health issues for this period, how NHMRC will deal with these issues and a strategy for medical research and public health research.
Our strategy for health and medical research
The themes of investment, translation and integrity represent NHMRC’s strategy for health and medical research. NHMRC will:
- create knowledge and build research capability through investment in the highest quality health and medical research and the best researchers
- drive the translation of health and medical research into clinical practice, policy and health systems and the effective commercialisation of research discoveries, supporting the pursuit of an Australian health system that is research-led, evidence-based, efficient and sustainable
- maintain a strong integrity framework for research and guideline development, underpinning rigorous and ethical research and relevant and accurate guidelines, and promoting community trust.
View the NHMRC Corporate Structure - See 'Downloads' section
The Federal Health Council (the precursor to the National Health and Medical Research Council) was established in 1926 following a Royal Commission's recommendations. Membership of the Council then consisted of the Commonwealth Director General of Health and the Chief Health Officer of each State.
The first meeting of the new NHMRC was held in February 1937 and was taken up mainly by discussion on medical research, including the 30,000 pounds allocated for grants in the first year. Since then the Council has consistently supported and stimulated health and medical research, keeping them closely linked to public-health issues and the community's need for health advice. In 1966-67, MREA appropriations exceeded $1 million for the first time and in 2018-19, the appropriation has increased to $829 million.
One of the inaugural grants went to John Carew Eccles (1903-1997), who in 1963 shared the Nobel Prize for Medicine with Sir Alan Hodgkin and Sir Andrew Huxley for his pioneering work on the chemical means by which signals are transmitted by nerve cells. Much of his research - primarily undertaken overseas - focused on the part of the brain that controls posture and movement.
NHMRC became an independent statutory agency within the portfolio of the Australian Government Minister for Health and Ageing, operating under the National Health and Medical Research Council Act 1992 (NHMRC Act) on 1 July 2006.